Home > Insider Trading > Filing (0001209191-23-050866)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1812364	Relay Therapeutics Inc.	RLAY	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1959229	Peter Rahmer	C/O Relay Therapeutics, Inc. 339 Binney Street, 2Nd Floor Cambridge MA 02139	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-06-30	1,662	$10.68	319,822	No	5	A	Direct
Common Stock	Disposition	2023-09-27	244	$8.38	318,226	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	A	Direct
No	4	S	Direct

Footnotes

The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.
In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 30, 2023.
Includes 290,341 shares underlying restricted stock units ("RSUs").
Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of RSUs on September 26, 2023. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
Prior to the reported transaction, the amount of securities beneficially owned by the reporting person was 318,470, with 284,835 shares underlying RSUs.
Includes 283,843 shares underlying RSUs.